Qualcomm and Boehringer Ingelheim Pharmaceuticals collaborate to add new digital technology to RESPIMAT ® inhaler

-- Two industry leaders combine strengths in health care and technology to aim to improve chronic obstructive pulmonary disease (COPD) care –
Source: Boehringer Ingelheim Press Releases - Category: Research Source Type: news